tiprankstipranks
Trending News
More News >
CS Diagnostics (CSDX)
OTHER OTC:CSDX
US Market

CS Diagnostics (CSDX) Financial Statements

Compare
18 Followers

CS Diagnostics Financial Overview

CS Diagnostics's market cap is currently $25.41M. The company's EPS TTM is $0; its P/E ratio is 1,850.00; CS Diagnostics is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23
Income Statement
Total Revenue$ 126.04K
Gross Profit$ 126.04K
Operating Income$ -22.00K
EBITDA$ -22.00K
Net Income$ -22.00K
Balance Sheet
Cash & Short-Term Investments$ 20.36K
Total Assets$ 499.42M
Total Debt$ 0.00
Net Debt$ -20.36K
Total Liabilities$ 12.82K
Stockholders' Equity$ 499.41M
Cash Flow
Free Cash Flow$ -499.44M
Operating Cash Flow$ 9.29K
Investing Cash Flow$ -499.44M
Financing Cash Flow$ 499.42M
Currency in USD

CS Diagnostics Earnings and Revenue History

CS Diagnostics Debt to Assets

CS Diagnostics Cash Flow

CS Diagnostics Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.